Please login to the form below
RWE
This page shows the latest RWE news and features for those working in and with pharma, biotech and healthcare.
Boehringer Ingelheim, Lifebit to use AI to detect infectious disease outbreaks
Lifebit’s AI-enabled real-world evidence (RWE) analysis system – REAL – uses advanced analytic capabilities to automatically let users known of any relevant outbreaks. ... At Lifebit, we thrive on connecting both locked-up sensitive biomedical data
Latest news
-
Who's calling the shots in European healthcare?
greater real-world evidence (RWE)? ... RWE sounds really nice, [but we have to step back] and understand who is proposing these solutions, and how they are being framed.
-
Europe urged to adapt faster to gene therapy challenges
European real world evidence (RWE) frameworks, in order to nurture the nascent cell and gene therapy revolution in the region. ... Better-adapted health technology assessment (HTA) methods, including greater use of real-world evidence (RWE) and
-
FDA and Flatiron extend real world evidence collaboration
In December it unveiled its strategic framework to advance RWE to support drug development, and also set up the Office of Drug Evaluation Science. ... Flatiron's Zach Weinberg. “In order for the entire industry to benefit from RWE, we must ensure that
-
IQVIA sees market slowdown looming for pharma
evidence (RWE) within clinical development.
-
Beneluxa: the future of European market access?
As the collection of real-world evidence (RWE) is part of the Spinraza agreement, I ask whether or not this will become standard in the future – and hand in hand with
More from news
Approximately 0 fully matching, plus 21 partially matching documents found.
Latest Intelligence
-
Adopting a holistic approach in crafting a product’s value story: utilising HEOR and RWE throughout the product life cycle
Proactively leverage HE models and RWE. Early HE models can be extremely advantageous as an initial activity to inform construction of a product’s value story. ... Similarly, lessons learned from RWE developed in the early phases of product development
-
Rare disease drug development – real-world evidence innovations with historical controls
By Will Maier. Rare disease drug development poses special challenges that can be overcome by using real-world evidence (RWE). ... Conclusion. RWE from rare diseases is available from a wide variety of sources for use as an HC in rare disease drug
-
Are smart deals a clever solution to UK market access?
Such deals also provide an excellent foundation for RWE generation, which is invaluable for both health systems and the industry to evaluate outcomes and assess value. ... And with the explosion of scientific innovation and digital technology in recent
-
Putting the ovation into innovation: trends from ESMO
The real value of real-world evidence in advanced breast cancer. Real-world evidence (RWE) is playing an ever- increasing role in treatment decision-making, in all forms of cancer. ... the ESMO 2020 Congress combination with endocrine therapy and
-
Understanding the ‘real world’ starts and ends with the patient
For that, we need real-world evidence (RWE) generated in real-world studies. ... This makes a network of robust, transparent and reliable RWE, such as PHederation, a vital tool.
More from intelligence
Approximately 0 fully matching, plus 27 partially matching documents found.
Latest appointments
-
OPEN Health appoints Stephen Chick as chief growth officer for Evidence & Access
as working with suppliers from the real-world evidence (RWE) and market access sectors. ... He was also vice president and general manager of life sciences at Allscripts, and senior vice president, RWE &Insights Clinical at inVentiv Health Clinical.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Genesis Research Insights & Evidence webinar 20 Oct: Reserve your place!
Join Priti Jhingran of Genesis Research and Tijana Ignjatovic of Market Access Transformation (MAT) for their webinar 'Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access' at 11am ET, 20
-
Leading pharmaceutical executive Jennifer Fillman joins evidence-based solution provider Genesis Research as Chief Financial Officer
International health economics and outcomes research (HEOR) and real-world evidence (RWE) organization Genesis Research has announced the appointment of Jennifer Fillman as its new Chief Financial Officer.
-
Impact of COVID-19 on the Biopsychosocial Model of Health
Tarry Ahuja, Manager of Program Development in Pharmaceutical Reviews and Senior RWE Advisor at CADTH, explores the impact of COVID-19 on the biopsychosocial model of health, key opportunities and barriers ... to RWE throughout the drug lifecycle, and
-
Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access
data suppliers in the HEOR, RWE, and market access space.
-
Genesis Research and Syapse combine forces to offer RWE and data to oncology innovators
Genesis Research is delighted to announce a strategic partnership with Syapse, combining the expertise and resources of both companies to better serve clients that are developing new oncology innovations. Genesis Research is delighted to announce a
More from PMHub
Approximately 18 fully matching, plus 15 partially matching documents found.
Subscribe to our email news alerts
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- AbbVie’s Rinvoq receives FDA approval for Crohn’s disease
- AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer
- Bayer’s Nubeqa combination recommended by NICE to treat metastatic prostate cancer
- Bristol Myers Squibb presents positive results for idiopathic pulmonary fibrosis drug
- Novo Nordisk announces positive phase 3 results for oral weight-loss drug
- Sanofi reports positive new data for multiple sclerosis treatment tolebrutinib
- Medscape Medical Affairs Selected as Finalist for 2023 Communiqué Awards
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Gene therapy, gene editing and perspectives on future use in Parkinson’s disease
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- Shining a Spotlight on Women’s Health Education Outcomes at ACOG 2023
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- ...
- Working together to achieve better patient pathways
- Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
- Design-thinking. Iterating for continuous improvement.
- How design can lead improvement within Pharma...
